{
    "root": "9f4d938d-3f9c-41b0-bb9b-82fd4487cf66",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": "Diclofenac Potassium",
    "value": "20250314",
    "ingredients": [
        {
            "name": "DICLOFENAC POTASSIUM",
            "code": "L4D5UA6CB4"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "MINERAL OIL",
            "code": "T5L8T28FGP"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        }
    ],
    "indications": "Diclofenac Potassium is indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older.",
    "contraindications": "Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1) The dosage is 25 mg four times a day",
    "warningsAndPrecautions": "Diclofenac Potassium 25 mg, are translucent, pale yellow, liquid-filled capsules printed with “X592” in black ink supplied as:Bottles of 120 Capsules NDC# 69315-275-20.\n                  StorageStore at room temperature 20° to 25°C (68° to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F)[see USP Controlled Room Temperature].\n                  Protect from moisture\n                  Dispense in tight container (USP).",
    "adverseReactions": "Diclofenac Potassium is contraindicated in the following patients:\n                  \n                     Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see Warnings and Precautions (5.7, 5.9)]\n                     \n                     History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.7, 5.8)]\n                     \n                     In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)]\n                     \n                     Diclofenac Potassium contains gelatin and is contraindicated in patients with known hypersensitivity to bovine protein."
}